Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms
Pancreatic neuroendocrine neoplasms (Pan-NENs) may exhibit a heterogeneous clinical course, ranging from indolent to progressive/metastatic behavior. In the latter scenario, streptozocin (STZ) is considered the cornerstone of systemic treatment; however, response to STZ-based chemotherapy may vary a...
Main Authors: | Giuseppe Fanciulli, Anna La Salvia, Sergio Di Molfetta, Giuseppe Cannavale, Giulia Puliani, Monica Verrico, Federica Campolo, Annamaria Colao, Antongiulio Faggiano, NIKE Group |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/24/7557 |
Similar Items
-
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
by: Giuseppe Fanciulli, et al.
Published: (2022-08-01) -
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
by: Roberta Modica, et al.
Published: (2022-11-01) -
The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms
by: Pasqualino Malandrino, et al.
Published: (2022-12-01) -
Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
by: Giovanni Vitale, et al.
Published: (2021-04-01) -
Editorial—Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education
by: Antongiulio Faggiano, et al.
Published: (2021-07-01)